|
|
intracellular bile acid receptor signaling pathway
|
GO:0038185 |
1 |
0.987
|
|
|
|
negative regulation of bile acid biosynthetic process
|
GO:0070858 |
3 |
0.884
|
|
|
|
drug catabolic process
|
GO:0042737 |
10 |
0.756
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.652
|
|
|
|
vitamin d receptor signaling pathway
|
GO:0070561 |
4 |
0.600
|
|
|
|
regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter
|
GO:0072366 |
1 |
0.457
|
|
|
|
drug transport
|
GO:0015893 |
8 |
0.421
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.398
|
|
|
|
drug export
|
GO:0046618 |
1 |
0.359
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.355
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.351
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.341
|
|
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
19 |
0.328
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.328
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.325
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.317
|
|
|
|
negative regulation of cholesterol storage
|
GO:0010887 |
4 |
0.316
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.312
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
26 |
0.306
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.306
|
|
|
|
regulation of apoptotic process involved in morphogenesis
|
GO:1902337 |
1 |
0.304
|
|
|
|
cellular response to xenobiotic stimulus
|
GO:0071466 |
29 |
0.289
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.275
|
|
|
|
regulation of sequestering of triglyceride
|
GO:0010889 |
8 |
0.272
|
|
|
|
regulation of cholesterol storage
|
GO:0010885 |
8 |
0.268
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
2 |
0.265
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.248
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
1 |
0.240
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.239
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.237
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.236
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.236
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.235
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.232
|
|
|
|
sequestering of triglyceride
|
GO:0030730 |
11 |
0.232
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.231
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.228
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.210
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.208
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.205
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.200
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.199
|
|
|
|
system process
|
GO:0003008 |
349 |
0.195
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.192
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
28 |
0.190
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
17 |
0.189
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.188
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
3 |
0.187
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.183
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.179
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
38 |
0.179
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.177
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.175
|
|
|
|
response to low density lipoprotein particle
|
GO:0055098 |
4 |
0.175
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.173
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.172
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.168
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.165
|
|
|
|
xenobiotic transport
|
GO:0042908 |
1 |
0.164
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.163
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.162
|
|
|
|
response to calcium ion
|
GO:0051592 |
46 |
0.156
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.155
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.152
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.151
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
54 |
0.151
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.149
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.149
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.148
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.145
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.142
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.140
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.140
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.138
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.138
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.137
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.133
|
Human |
|
|
regulation of calcium ion transport
|
GO:0051924 |
79 |
0.133
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.132
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.128
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.127
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.125
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.123
|
|
|
|
drug metabolic process
|
GO:0017144 |
19 |
0.122
|
|
|
|
response to xenobiotic stimulus
|
GO:0009410 |
30 |
0.121
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.121
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
67 |
0.121
|
|
|
|
positive regulation of oxidoreductase activity
|
GO:0051353 |
26 |
0.119
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.119
|
|
|
|
regulation of keratinocyte proliferation
|
GO:0010837 |
11 |
0.116
|
|
|
|
glucan metabolic process
|
GO:0044042 |
22 |
0.115
|
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.114
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.114
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
27 |
0.111
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.110
|
|
|
|
response to retinoic acid
|
GO:0032526 |
33 |
0.109
|
|
|
|
negative regulation of cytokine mediated signaling pathway
|
GO:0001960 |
22 |
0.109
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.109
|
Human |
|
|
regulation of vitamin d 24 hydroxylase activity
|
GO:0010979 |
3 |
0.107
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.106
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.105
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.103
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.103
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.102
|
|
|
|
positive regulation of vitamin d 24 hydroxylase activity
|
GO:0010980 |
3 |
0.102
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.099
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.099
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.099
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.098
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.097
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.096
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.095
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.095
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.093
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.092
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.091
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.091
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.089
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.089
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
22 |
0.089
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.089
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.089
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.089
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.088
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.088
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.087
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.084
|
|
|
|
intestinal absorption
|
GO:0050892 |
4 |
0.083
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.083
|
|
|
|
ornithine metabolic process
|
GO:0006591 |
3 |
0.082
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.081
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.081
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
46 |
0.081
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.081
|
|
|
|
regulation of glycogen metabolic process
|
GO:0070873 |
15 |
0.080
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.080
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.080
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.080
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.079
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.079
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.079
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.077
|
|
|
|
exogenous drug catabolic process
|
GO:0042738 |
8 |
0.077
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.077
|
|
|
|
vitamin d metabolic process
|
GO:0042359 |
10 |
0.076
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.076
|
|
|
|
cell aggregation
|
GO:0098743 |
1 |
0.076
|
|
|
|
midgut development
|
GO:0007494 |
1 |
0.075
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.075
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.074
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.074
|
|
|
|
xenobiotic metabolic process
|
GO:0006805 |
28 |
0.073
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.072
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.072
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
52 |
0.071
|
|
|
|
regulation of macrophage derived foam cell differentiation
|
GO:0010743 |
14 |
0.071
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
47 |
0.070
|
|
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
43 |
0.070
|
|
|
|
bile acid biosynthetic process
|
GO:0006699 |
10 |
0.070
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.069
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.069
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
22 |
0.068
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.068
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.068
|
|
|
|
negative regulation of response to interferon gamma
|
GO:0060331 |
2 |
0.067
|
|
|
|
response to vitamin d
|
GO:0033280 |
10 |
0.067
|
|
|
|
regulation of alcohol biosynthetic process
|
GO:1902930 |
22 |
0.067
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.066
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.066
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.065
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.065
|
|
|
|
negative regulation of smooth muscle cell proliferation
|
GO:0048662 |
14 |
0.065
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.065
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.065
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.064
|
|
|
|
lipid transport
|
GO:0006869 |
90 |
0.063
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.063
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
33 |
0.063
|
|
|
|
bile acid metabolic process
|
GO:0008206 |
14 |
0.062
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.062
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
2 |
0.062
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.061
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
24 |
0.060
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.060
|
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
8 |
0.060
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.059
|
Human |
|
|
central nervous system development
|
GO:0007417 |
123 |
0.059
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.059
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
28 |
0.059
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.059
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.058
|
|
|
|
axon regeneration
|
GO:0031103 |
1 |
0.058
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.057
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.057
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.057
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.057
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.057
|
|
|
|
lipid homeostasis
|
GO:0055088 |
39 |
0.056
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.056
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.056
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.056
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.056
|
|
|
|
cholesterol storage
|
GO:0010878 |
9 |
0.056
|
|
|
|
smooth muscle cell proliferation
|
GO:0048659 |
28 |
0.056
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.056
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.056
|
|
|
|
regulation of smooth muscle cell proliferation
|
GO:0048660 |
28 |
0.056
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
41 |
0.055
|
|
|
|
head development
|
GO:0060322 |
108 |
0.055
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.055
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.054
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.054
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.054
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.054
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.054
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.054
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
23 |
0.053
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.053
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.052
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.052
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.052
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.051
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.051
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.051
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.050
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.050
|
|
|
|
cellular response to vitamin d
|
GO:0071305 |
5 |
0.050
|
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.050
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.049
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.049
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.049
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.048
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.048
|
Rat |
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.048
|
|
|
|
secretion by tissue
|
GO:0032941 |
9 |
0.048
|
|
|
|
lactation
|
GO:0007595 |
3 |
0.048
|
|
|
|
negative regulation of response to cytokine stimulus
|
GO:0060761 |
25 |
0.047
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.047
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.047
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.047
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.047
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.046
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.046
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.046
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
67 |
0.046
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.046
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
19 |
0.046
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.046
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
43 |
0.045
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.045
|
|
|
|
glycolytic process
|
GO:0006096 |
17 |
0.045
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
44 |
0.045
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.045
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.044
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.044
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.044
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.044
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.044
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.044
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.044
|
|
|
|
digestive system process
|
GO:0022600 |
17 |
0.044
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.044
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.044
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.043
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.043
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.043
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.043
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.043
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.043
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.043
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
30 |
0.043
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.042
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.042
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.042
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.042
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.042
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.042
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.042
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.041
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.041
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.041
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.041
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
1 |
0.041
|
|
|
|
sterol homeostasis
|
GO:0055092 |
28 |
0.041
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.041
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.040
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.040
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.040
|
|
|
|
response to estradiol
|
GO:0032355 |
23 |
0.040
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.040
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
26 |
0.040
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.040
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.040
|
|
|
|
decidualization
|
GO:0046697 |
4 |
0.040
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
32 |
0.040
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.040
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.039
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.039
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.039
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.039
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.039
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.039
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.039
|
|
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
3 |
0.039
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.038
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.038
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.038
|
|
|
|
regulation of monooxygenase activity
|
GO:0032768 |
22 |
0.038
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.037
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.037
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.037
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.037
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.037
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
36 |
0.036
|
|
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
4 |
0.036
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.036
|
|
|
|
regulation of glycolytic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072361 |
2 |
0.036
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.036
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.036
|
|
|
|
digestion
|
GO:0007586 |
22 |
0.036
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.036
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
18 |
0.035
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.035
|
|
|
|
positive regulation of cortisol biosynthetic process
|
GO:2000066 |
1 |
0.035
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.035
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.035
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.035
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.035
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.035
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
1 |
0.034
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.034
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.034
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.034
|
|
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.034
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.034
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.034
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.034
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.034
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.033
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.033
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.033
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.033
|
|
|
|
negative regulation of lipid biosynthetic process
|
GO:0051055 |
22 |
0.033
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.033
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.033
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.033
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.033
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.033
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.033
|
|
|
|
positive regulation of interleukin 5 production
|
GO:0032754 |
3 |
0.033
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.033
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.032
|
|
|
|
regulation of lipid transport by regulation of transcription from rna polymerase ii promoter
|
GO:0072367 |
4 |
0.032
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.032
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.032
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.032
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.032
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.032
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.032
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.032
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.032
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.031
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.031
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.031
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.031
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.031
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.031
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.031
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.031
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.031
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.031
|
Human |
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.031
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.030
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
162 |
0.030
|
|
|
|
glucose metabolic process
|
GO:0006006 |
45 |
0.030
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.030
|
|
|
|
positive regulation of glucocorticoid metabolic process
|
GO:0031945 |
1 |
0.030
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.030
|
|
|
|
regulation of polysaccharide metabolic process
|
GO:0032881 |
21 |
0.030
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
41 |
0.030
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.030
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.030
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.029
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.029
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.029
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.029
|
Human |
|
|
behavior
|
GO:0007610 |
112 |
0.029
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.029
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.029
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.029
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.029
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.029
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.028
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
11 |
0.028
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.028
|
|
|
|
cellular response to alcohol
|
GO:0097306 |
29 |
0.028
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.028
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.028
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.028
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.028
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.027
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.027
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.027
|
|
|
|
mesonephric duct development
|
GO:0072177 |
3 |
0.027
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.027
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.027
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.027
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.027
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.026
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.026
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus
|
GO:1901522 |
2 |
0.026
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.026
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
3 |
0.026
|
|
|
|
interaction with host
|
GO:0051701 |
42 |
0.026
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.026
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.026
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.026
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.025
|
|
|
|
regulation of glycolytic by positive regulation of transcription from rna polymerase ii promoter
|
GO:0072363 |
1 |
0.025
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.025
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
20 |
0.025
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
9 |
0.025
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.025
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.025
|
|
|
|
body fluid secretion
|
GO:0007589 |
9 |
0.025
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.025
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
24 |
0.025
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.025
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.025
|
|
|
|
canonical wnt signaling pathway involved in cardiac muscle cell fate commitment
|
GO:0061317 |
3 |
0.025
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.025
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.025
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.024
|
|
|
|
response to axon injury
|
GO:0048678 |
1 |
0.024
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.024
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.024
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.024
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
4 |
0.024
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.024
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.024
|
|
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
46 |
0.024
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.024
|
|
|
|
hemostasis
|
GO:0007599 |
76 |
0.024
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.023
|
|
|
|
regulation of cell cell adhesion
|
GO:0022407 |
57 |
0.023
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.023
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.023
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.023
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.023
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.023
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.023
|
|
|
|
cellular response to peptide
|
GO:1901653 |
59 |
0.023
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
47 |
0.023
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.023
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.023
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
68 |
0.023
|
|
|
|
mating
|
GO:0007618 |
1 |
0.022
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.022
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.022
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.022
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.022
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.022
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.022
|
|
|
|
positive regulation of tooth mineralization
|
GO:0070172 |
2 |
0.022
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.022
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.022
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.022
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.022
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.022
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.022
|
Human |
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.021
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.021
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.021
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.021
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.021
|
|
|
|
regulation of transcription involved in lymphatic endothelial cell fate commitment
|
GO:0060849 |
2 |
0.021
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.021
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.021
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.021
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.021
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.021
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.021
|
|
|
|
neuronal action potential
|
GO:0019228 |
9 |
0.021
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.021
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.021
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.021
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.021
|
|
